skip to main content
Idioma:
Refinado por: Nome da Publicação: Open Forum Infectious Diseases remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Efficacy and Safety of Oritavancin Relative to Vancomycin for Patients with Acute Bacterial Skin and Skin Structure Infections (ABSSSI) in the Outpatient Setting: Results From the SOLO Clinical Trials
Efficacy and Safety of Oritavancin Relative to Vancomycin for Patients with Acute Bacterial Skin and Skin Structure Infections (ABSSSI) in the Outpatient Setting: Results From the SOLO Clinical Trials
Material Type:
Artigo 		Adicionar ao Meu Espaço

Efficacy and Safety of Oritavancin Relative to Vancomycin for Patients with Acute Bacterial Skin and Skin Structure Infections (ABSSSI) in the Outpatient Setting: Results From the SOLO Clinical Trials

Lodise, Thomas P ; Redell, Mark ; Armstrong, Shannon O ; Sulham, Katherine A ; Corey, G Ralph

Open forum infectious diseases, 2017-01, Vol.4 (1), p.ofw274-ofw274 [Periódico revisado por pares]

United States: Oxford University Press

Texto completo disponível

Citações Citado por
2
Prolonged Use of Oritavancin for Vancomycin-Resistant Enterococcus faecium Prosthetic Valve Endocarditis
Prolonged Use of Oritavancin for Vancomycin-Resistant Enterococcus faecium Prosthetic Valve Endocarditis
Material Type:
Artigo 		Adicionar ao Meu Espaço

Prolonged Use of Oritavancin for Vancomycin-Resistant Enterococcus faecium Prosthetic Valve Endocarditis

Johnson, Jennifer A ; Feeney, Eoin R ; Kubiak, David W ; Corey, G. Ralph

Open forum infectious diseases, 2015-12, Vol.2 (4), p.ofv156-ofv156 [Periódico revisado por pares]

United States: Oxford University Press

Texto completo disponível

Citações Citado por
3
849. Reduced CIED Infections with an Antibacterial Envelope: Microbiologic Analysis of the WRAP-IT Study
849. Reduced CIED Infections with an Antibacterial Envelope: Microbiologic Analysis of the WRAP-IT Study
Material Type:
Artigo 		Adicionar ao Meu Espaço

849. Reduced CIED Infections with an Antibacterial Envelope: Microbiologic Analysis of the WRAP-IT Study

Sohail, Muhammad R ; Corey, G Ralph ; Wilkoff, Bruce L ; Poole, Jeanne ; Mittal, Suneet ; Kennergren, Charles ; Greenspon, Arnold J ; Cheng, Alan ; Lande, Jeff ; Lexcen, Daniel R ; Tarakji, Khaldoun

Open forum infectious diseases, 2019-10, Vol.6 (Supplement_2), p.S16-S16 [Periódico revisado por pares]

US: Oxford University Press

Texto completo disponível

Citações Citado por
4
Comparison of Safety Profile of Delafloxacin (DLX) vs. Vancomycin/Aztreonam (VAN/AZ) in theTreatment of Patients with Acute Bacterial Skin and Skin Structure Infections (ABSSSI): Integrated Safety Findings from Two Phase III Studies
Comparison of Safety Profile of Delafloxacin (DLX) vs. Vancomycin/Aztreonam (VAN/AZ) in theTreatment of Patients with Acute Bacterial Skin and Skin Structure Infections (ABSSSI): Integrated Safety Findings from Two Phase III Studies
Material Type:
Artigo 		Adicionar ao Meu Espaço

Comparison of Safety Profile of Delafloxacin (DLX) vs. Vancomycin/Aztreonam (VAN/AZ) in theTreatment of Patients with Acute Bacterial Skin and Skin Structure Infections (ABSSSI): Integrated Safety Findings from Two Phase III Studies

Corey, G Ralph ; Hooper, David ; P. Lodise, Thomas ; Tseng, Carol ; Cammarata, Sue K

Open forum infectious diseases, 2017-10, Vol.4 (suppl_1), p.S533-S533 [Periódico revisado por pares]

US: Oxford University Press

Texto completo disponível

Citações Citado por
5
1338. A Pooled Analysis of Patients With Wound Infections in the Phase 3 REVIVE Trials: Randomized, Double-blind Studies to EValuate the Safety and Efficacy of Iclaprim Vs. Vancomycin for trEatment of Acute Bacterial Skin and Skin Structure Infections
1338. A Pooled Analysis of Patients With Wound Infections in the Phase 3 REVIVE Trials: Randomized, Double-blind Studies to EValuate the Safety and Efficacy of Iclaprim Vs. Vancomycin for trEatment of Acute Bacterial Skin and Skin Structure Infections
Material Type:
Artigo 		Adicionar ao Meu Espaço

1338. A Pooled Analysis of Patients With Wound Infections in the Phase 3 REVIVE Trials: Randomized, Double-blind Studies to EValuate the Safety and Efficacy of Iclaprim Vs. Vancomycin for trEatment of Acute Bacterial Skin and Skin Structure Infections

Huang, David ; Corey, G Ralph ; Holland, Thomas L ; Lodise, Thomas P ; O’Rirodan, William ; Wilcox, Mark ; File, Thomas M ; Dryden, Matthew ; Torres, Antoni ; Balser, Barbara ; Desplats, Eve

Open forum infectious diseases, 2018-11, Vol.5 (suppl_1), p.S409-S409 [Periódico revisado por pares]

US: Oxford University Press

Texto completo disponível

Citações Citado por
6
A Phase 3, Randomized, Double-Blind, Multicenter Study to Evaluate the Safety and Efficacy of Intravenous Iclaprim vs. Vancomycin in the Treatment of Acute Bacterial Skin and Skin Structure Infections Suspected or Confirmed to be Due to Gram-Positive Pathogens (REVIVE-1)
A Phase 3, Randomized, Double-Blind, Multicenter Study to Evaluate the Safety and Efficacy of Intravenous Iclaprim vs. Vancomycin in the Treatment of Acute Bacterial Skin and Skin Structure Infections Suspected or Confirmed to be Due to Gram-Positive Pathogens (REVIVE-1)
Material Type:
Artigo 		Adicionar ao Meu Espaço

A Phase 3, Randomized, Double-Blind, Multicenter Study to Evaluate the Safety and Efficacy of Intravenous Iclaprim vs. Vancomycin in the Treatment of Acute Bacterial Skin and Skin Structure Infections Suspected or Confirmed to be Due to Gram-Positive Pathogens (REVIVE-1)

Huang, David ; Mcleroth, Patrick ; Shukla, Rajesh ; File, Thomas M ; Wilcox, Mark ; Torres, Antoni ; Liu, Alyssa ; O’riordan, William ; Overcash, Scott ; Dryden, Matthew ; Corey, G Ralph ; Heller, Barry

Open forum infectious diseases, 2017-10, Vol.4 (suppl_1), p.S536-S536 [Periódico revisado por pares]

US: Oxford University Press

Texto completo disponível

Citações Citado por
7
Analysis of CAMERA-1 S. aureus Bacteremia Trial Results Using the DOOR
Analysis of CAMERA-1 S. aureus Bacteremia Trial Results Using the DOOR
Material Type:
Artigo 		Adicionar ao Meu Espaço

Analysis of CAMERA-1 S. aureus Bacteremia Trial Results Using the DOOR

Holland, Thomas L ; Davis, Joshua S ; Doernberg, Sarah B ; Tran, Thuy Tien T ; Evans, Scott R ; Cosgrove, Sara E ; Boucher, Helen W ; Corey, G Ralph ; Fowler, Vance ; Chambers, Henry F ; Tong, Steven Y. C

Open forum infectious diseases, 2017-10, Vol.4 (suppl_1), p.S541-S541 [Periódico revisado por pares]

US: Oxford University Press

Texto completo disponível

Citações Citado por
8
Doing the Same with Less: A Randomized, Multinational, Open-Label, Adjudicator-Blinded Trial of an Algorithm vs. Standard of Care to Determine Treatment Duration for Staphylococcal Bacteremia
Doing the Same with Less: A Randomized, Multinational, Open-Label, Adjudicator-Blinded Trial of an Algorithm vs. Standard of Care to Determine Treatment Duration for Staphylococcal Bacteremia
Material Type:
Artigo 		Adicionar ao Meu Espaço

Doing the Same with Less: A Randomized, Multinational, Open-Label, Adjudicator-Blinded Trial of an Algorithm vs. Standard of Care to Determine Treatment Duration for Staphylococcal Bacteremia

Holland, Thomas L ; Boucher, Helen W ; Raad, Issam ; Anderson, Deverick J ; Cosgrove, Sara E ; Aycock, Suzanne ; Baddley, John W ; Chow, Shein-Chung ; Chu, Vivian H ; Cook, Paul P ; Corey, G Ralph ; Daly, Jennifer S ; Hachem, Ray Y ; Chaftari, Anne-Marie ; Horton, James M ; Jenkins, Timothy C ; Gu, Jiezhun ; Levine, Donald P ; Miro, Jose M ; Riska, Paul ; Rubin, Zachary A ; Rupp, Mark E ; Schrank, John ; Sims, Matthew ; Wray, Dannah ; Zervos, Marcus J ; Fowler, Vance

Open forum infectious diseases, 2017-10, Vol.4 (suppl_1), p.S29-S29 [Periódico revisado por pares]

US: Oxford University Press

Texto completo disponível

Citações Citado por

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Data de Publicação 

De até
Refinar

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.